Sridharan, Swetha
Day, Fiona
Loh, Jasmin
Lynam, James
Smart, Joanne
Holt, Brandan
Mandaliya, Hiren
Bonaventura, Anthony
Kumar, Mahesh
Martin, Jarad
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer
https://doi.org/10.1186/s13014-022-02127-x
Article History
Received: 17 March 2022
Accepted: 5 September 2022
First Online: 14 September 2022
Declarations
:
: All patients provided written informed consent, and the study was reviewed and approved by the Hunter New England Human Research Ethics Committee (Approval 2019/ETH00815).
: All patients provided written informed consent.
: The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.